ADAMTS-13 activity in stroke of known and unknown cause: Relation to vascular risk factor burden

Gerrit M Grosse1, Andrei Leotescu1, Jan-Thorben Sieweke2

  • 1Department of Neurology, Hannover Medical School, Hannover, Germany.

Frontiers in Neurology
|January 27, 2023
PubMed

Insights

A disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS-13) activity is lower in patients with more vascular risk factors for stroke. This suggests ADAMTS-13 may play a role in cerebrovascular risk.

Area of Science:

  • Neurology
  • Vascular Biology
  • Biochemistry

Background:

  • Understanding ischemic stroke mechanisms is crucial for secondary prevention strategies.
  • A disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS-13) possesses antithrombotic properties and is implicated in stroke pathophysiology.
  • The association between ADAMTS-13 and stroke etiology, along with vascular risk factors, requires further investigation.

Purpose of the Study:

  • To investigate the association between ADAMTS-13 activity and stroke etiology.
  • To explore the relationship between ADAMTS-13 activity and the burden of vascular risk factors in stroke patients.

Main Methods:

  • ADAMTS-13 activity was measured in two prospectively recruited stroke cohorts.
  • Cohort 1 included patients with stroke due to ESUS, AF, large-artery atherosclerosis, or small vessel disease (n=88).
  • Cohort 2 comprised patients with cryptogenic stroke and PFO undergoing PFO closure (n=38).
  • Vascular risk factor burden was assessed using CHA2DS2VASC, ESRS, and RoPE scores.

Main Results:

  • ADAMTS-13 activity was lower in AF-related stroke patients compared to ESUS patients, though this was confounded by vascular risk factors.
  • ADAMTS-13 activity showed an inverse correlation with ESRS (r=-0.452, p<0.001) and CHA2DS2VASC (r=-0.375, p<0.001) in cohort 1.
  • A positive correlation was observed between ADAMTS-13 activity and the RoPE score in cohort 2 (r=0.413, p=0.010).

Conclusions:

  • ADAMTS-13 activity is inversely correlated with the number of vascular risk factors across various stroke etiologies.
  • These findings suggest a potential role for ADAMTS-13 in mediating cerebrovascular risk.
  • Further research is warranted to elucidate the precise role of ADAMTS-13 in stroke pathophysiology and prevention.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.4K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
35
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18